Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B
Abstract Immunogenicity of vaccines against meningococcal serogroup B (MenB) has been assessed pre-licensure with a human serum bactericidal activity assay (hSBA), tested against small numbers of strains. We report the qualification/validation of an alternative qualitative hSBA which uses endogenous...
Enregistré dans:
Auteurs principaux: | Annett Kleinschmidt, Kumaran Vadivelu, Laura Serino, Nina Neidig, Bertrand de Wergifosse |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d2bbc49e56634308bbf07266dd7e19c1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Toward an Improved Meningococcal Serogroup B Assay
par: Jan Poolman
Publié: (2018) -
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
par: Lisa K. McNeil, et autres
Publié: (2018) -
Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland
par: Margherita Bodini, et autres
Publié: (2020) -
Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine
par: Henju Marjuki, et autres
Publié: (2019) -
The stability of complement-mediated bactericidal activity in human serum against Salmonella.
par: Colette M O'Shaughnessy, et autres
Publié: (2012)